The gamma-gamma isoenzyme of the cytoplasmic enzyme enolase, known as neuron-specific enolase (NSE), has been demonstrated in neurons and neuroendocrine cells. In normal tissues, most neurons and their axonal and dendritic processes stain strongly positive for NSE, with the exception of Purkinje cells. NSE has been demonstrated in Schwann cells, ganglioneuromas, neuroblastoma, schwannomas, malignant melanomas, pheochromocytoma, paragangliomas, carcinoids, medullary thyroid carcinomas, pituitary adenomas, pancreas and GI tract endocrine tumors, and small cell carcinoma of the lung. A number of non-neuronal and nonendocrine tumors may also express NSE. NSE positivity should not be relied upon entirely as evidence of the neuronal or neuroendocrine differentiation of a given neoplasm.
|Tissue Type/Cancer Type||
6 mL – Manual – RTU, 100 Tests – Automation – i6000, 1 mL – Manual – Concentrate, 0.5 mL – Manual – Concentrate, 50 Tests – Automation – Xmatrx, 50 tests – NanoVIP®, 160 Tests – Automation – Xmatrx, 5 slides – Xmatrx, 5 slides – Manual